FDA Inspection 1013091 — Chunghwa Chemical Synthesis & Biotech Co., Ltd
The FDA completed an inspection of Chunghwa Chemical Synthesis & Biotech Co., Ltd on Mar 29, 2017 in New Taipei City. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 29, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- New Taipei City (Taiwan)